Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Valeo Pharmainc (VPH.TO)

Valeo Pharmainc (VPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
VALEO PHARMA ANNOUNCES LEADERSHIP CHANGES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that the...

VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA ANNOUNCES SENIOR EXECUTIVE APPOINTMENT AND BOARD OF DIRECTORS CHANGE

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Mr. Al...

AGN.AX : 0.790 (+1.28%)
VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA REPORTS RECORD SECOND QUARTER 2024 REVENUES

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today reported its financial...

VPH.TO : 0.0750 (-6.25%)
VPHIF : 0.0940 (+78.03%)
Stocks in play: Valeo Phama Inc.

Today announced that it has undertaken a restructuring of its commercial field operations aimed at improving ...

VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA ANNOUNCES RESTRUCTURING OF COMMERCIAL FIELD OPERATIONS TO SUPPORT PATH TO PROFITABILITY

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that it has...

VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
Stocks in play: Valeo Pharma Inc.

Announced today that it will report its financial results and highlights for the second quarter ended ...

VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA TO HOST SECOND QUARTER 2024 RESULTS CONFERENCE CALL / WEBCAST

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, announced today that it will...

VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of...

VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
VALEO PHARMA TO PRESENT AT THE 2024 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE

/CNW/ - Valeo Pharma Inc. (TSX: VPH) (OTCQB: VPHIF) (FSE: VP2) ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced that Steve...

VPHIF : 0.0940 (+78.03%)
VPH.TO : 0.0750 (-6.25%)
Stocks in play: Valeo Pharma Inc.

Announced that Al Moghaddam has joined the Company's Board of Directors. Valeo Pharma Inc. shares T.VPH ...

VPH.TO : 0.0750 (-6.25%)

Barchart Exclusives

MSFT vs. ORCL: Which AI Software Stock is a Better Buy?
Microsoft and Oracle have been leaders in developing market-leading AI software. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar